Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Smith, Charles
Item TypeName
Academic Article A novel sphingosine kinase inhibitor induces autophagy in tumor cells.
Academic Article Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.
Academic Article Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase.
Academic Article Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts.
Academic Article Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion.
Academic Article Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.
Academic Article Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.
Concept Adamantane
Academic Article Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.
Academic Article The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo.
Academic Article Tissue biomarkers of drug efficacy: case studies using a MALDI-MSI workflow.
Academic Article Targeting NF?B mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
Academic Article Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640.
Academic Article A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
Academic Article ABC294640, A Novel Sphingosine Kinase 2 Inhibitor, Induces Oncogenic Virus-Infected Cell Autophagic Death and Represses Tumor Growth.
Academic Article Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression.
Academic Article Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells.
Search Criteria
  • Adamantane